Home/Hedge Fund Intelligence/Vera Therapeutics, Inc.
Nasdaq: VERAStockForm 13F30 Jun 2026

Hedge funds that hold Vera Therapeutics, Inc. Class A Nasdaq: VERA

Class A · CUSIP 92337R101 · who reports it, how much, and how much it matters to them

38 of the 720 hedge fund managers we track reported shares of Vera Therapeutics, Inc. (Nasdaq: VERA) on Form 13F for 30 June 2026. Between them they reported USD 1bn. The largest position belongs to Avoro Capital Advisors, at USD 246m. The manager with the most riding on it is Kynam Capital Management, where it is 6.9% of the reported book.

Managers reporting it38of 720 we track
Value they reportUSD 1bnshares only, 30 Jun 2026
Funds they run413with a file on PPLI.com
Largest positionUSD 246mAvoro Capital Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight6.9%Kynam Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

38 managers, USD 1bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Vera Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Avoro Capital Advisors1 fund on PPLI.comUSD 246m2.2%
2Deep Track Capital1 fund on PPLI.comUSD 172m2.5%
3Kynam Capital Management1 fund on PPLI.comUSD 124m6.9%
4Sofinnova Investments1 fund on PPLI.comUSD 120m6.2%
5Eversept Partners3 funds on PPLI.comUSD 95m4.9%
6Logos Global Management1 fund on PPLI.comUSD 94m4.1%
7Great Point Partners2 funds on PPLI.comUSD 26m4.9%
8Braidwell12 funds on PPLI.comUSD 24m0.9%
9Rock Springs Capital Management2 funds on PPLI.comUSD 18m0.9%
10Balyasny Asset Management25 funds on PPLI.comUSD 16m0.0%
11Orbimed Advisors1 fund on PPLI.comUSD 16m0.3%
12Armistice Capital1 fund on PPLI.comUSD 13m0.2%
13Renaissance Technologies13 funds on PPLI.comUSD 12m0.0%
14Millennium Management6 funds on PPLI.comUSD 12m0.0%
15PFM Health Sciences3 funds on PPLI.comUSD 9.6m0.8%
16Platinum Investment Management11 funds on PPLI.comUSD 4.9m1.2%
17Engineers Gate Manager1 fund on PPLI.comUSD 4.6m0.1%
18HighVista Strategies27 funds on PPLI.comUSD 4.5m1.0%
19Squarepoint Ops7 funds on PPLI.comUSD 4.5m0.0%
20Two Sigma Investments35 funds on PPLI.comUSD 4.5m0.0%
21Boothbay Fund Management2 funds on PPLI.comUSD 4.3m0.1%
22Exome Asset Management2 funds on PPLI.comUSD 4.2m2.6%
23D. E. Shaw & Co.15 funds on PPLI.comUSD 3.2m0.0%
24Neo Ivy Capital Management1 fund on PPLI.comUSD 2.1m0.5%
25POINT72 Asset Management17 funds on PPLI.comUSD 1.7m0.0%
26LMR Partners2 funds on PPLI.comUSD 1.7m0.0%
27Verdad Advisers6 funds on PPLI.comUSD 1m1.0%
28Verition Fund Management3 funds on PPLI.comUSD 972,0000.0%
29Persistent Asset Partners10 funds on PPLI.comUSD 707,0000.2%
30Cinctive Capital Management5 funds on PPLI.comUSD 532,0000.0%
31Exoduspoint Capital Management7 funds on PPLI.comUSD 480,0000.0%
32Nine Masts Capital1 fund on PPLI.comUSD 405,0000.0%
33Marshall Wace LLP84 funds on PPLI.comUSD 323,0000.0%
34Entrypoint Capital1 fund on PPLI.comUSD 311,0000.1%
35Magnetar Financial93 funds on PPLI.comUSD 300,0000.0%
36Bayforest Capital1 fund on PPLI.comUSD 122,0000.1%
37The Quarry1 fund on PPLI.comUSD 62,6500.0%
38Graticule Asia Macro Advisors8 funds on PPLI.comUSD 11,1570.0%
Next: where it matters most
Where it matters most

For Kynam Capital Management it is 6.9% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kynam Capital ManagementUSD 124m6.9%
2Sofinnova InvestmentsUSD 120m6.2%
3Eversept PartnersUSD 95m4.9%
4Great Point PartnersUSD 26m4.9%
5Logos Global ManagementUSD 94m4.1%
6Exome Asset ManagementUSD 4.2m2.6%
7Deep Track CapitalUSD 172m2.5%
8Avoro Capital AdvisorsUSD 246m2.2%
9Platinum Investment ManagementUSD 4.9m1.2%
10HighVista StrategiesUSD 4.5m1.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Vera Therapeutics, Inc.

What is the ticker symbol of Vera Therapeutics, Inc.?

Vera Therapeutics, Inc. trades under the symbol VERA on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92337R101.

Which hedge funds own Vera Therapeutics, Inc. (Nasdaq: VERA)?

38 of the 720 hedge fund managers PPLI.com tracks reported Vera Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Avoro Capital Advisors (USD 246m), Deep Track Capital (USD 172m), Kynam Capital Management (USD 124m), Sofinnova Investments (USD 120m) and Eversept Partners (USD 95m).

How many hedge funds hold Vera Therapeutics, Inc.?

38 managers in our coverage reported it, and between them they run 413 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Vera Therapeutics, Inc.?

Kynam Capital Management, where the position was 6.9% of the reported 13F book at 30 June 2026.

Does this show who is short Vera Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Vera Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.